II. Scope of Use; Limitations
III. Forward Looking Statements; Safe Harbor
Statements made in, or accessible through the Web Site, regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding Regenacy’s ability to successfully initiate and complete clinical trials and development programs, the expected timing for reporting of top-line data, Regenacy’s ability to obtain regulatory approval, market penetration and acceptance of any of its products and the initiation of clinical studies. Risks that contribute to the uncertain nature of the forward-looking statements include: Regenacy’s future preclinical studies and clinical trials may not be successful; changes in regulatory requirements in the United States and foreign countries may prevent or significantly delay regulatory approval of Regenacy’s products; Regenacy may change its plans to develop and commercialize its product candidates; the FDA may not agree with Regenacy’s interpretation of the data from clinical trials; Regenacy may decide, or the FDA may require Regenacy, to conduct additional clinical trials or to modify Regenacy clinical trials; Regenacy may experience delays in the commencement, enrollment, completion or analysis of clinical testing for its product candidates, or significant issues regarding the adequacy of its clinical trial designs or the execution of its clinical trials, which could result in increased costs and delays, or limit Regenacy’s ability to obtain regulatory approval; the third parties with whom Regenacy has partnered with for the development of its products and upon whom Regenacy relies to conduct its clinical trials and manufacture its product candidates may not perform as expected; Regenacy may not receive regulatory approval for its products or be successfully commercialized; unexpected adverse side effects or inadequate therapeutic efficacy of any of its products could delay or prevent regulatory approval or commercialization; Regenacy may be unable to obtain and maintain intellectual property protection for its product candidates; the loss of key scientific or management personnel; Regenacy’s ability to obtain additional financing; and the accuracy of Regenacy’s estimates regarding expenses, future revenues and capital requirements. Without limiting the following paragraph, all forward-looking statements contained in this Web Site speak only as of the date on which they were made. Regenacy undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.
IV. Copyrights; Trademarks
All content included on this Web Site, such as text, graphics, art work, button icons, images, scientific illustrations, photographs, audio clips, video clips, digital downloads, data compilations, user interface and software (collectively, the “Copyrighted Materials”) is the property of Regenacy, or its content suppliers or licensors, and the compilation (meaning the collection, arrangement, and assembly) of all content on this Web Site is the property of Regenacy, and are protected by U.S. and international copyright laws. The Regenacy logos and trademarks, as well as all other names, logos, slogans, images, marks, trade names, and trademarks used on this Web Site (collectively, the “Trademarks”) are the properties of their respective owners and are protected by trademark laws. Regenacy hereby grants you permission to view and use Copyrighted Material available on the site in connection with your informational, personal, non-commercial use of the Web Site as authorized above. Any other use of the Copyrighted Materials, including but not limited to the reproduction, republication, modification, distribution, transmission, performance, or distribution of the same, is strictly prohibited and may be a violation of applicable law. Nothing contained on this Web Site should be construed as granting, explicitly, implicitly or otherwise, any license or right to use any Regenacy Trademarks without the prior written permission of Regenacy, or to use the Trademarks of any third party.
V. Submitted Information
VI. Links to Other Web Sites
VII. Disclaimers; Disclaimers of Warranty; Limitation of Liability
SOME STATES DO NOT ALLOW THE EXCLUSION OF CERTAIN WARRANTIES OR LIMITATION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES. ACCORDINGLY, IN SUCH STATES, THE LIABILITY OF THE REGENACY PARTIES SHALL BE LIMITED TO THE GREATEST EXTENT PERMITTED BY LAW.
IF YOU ARE FROM NEW JERSEY, THE FOREGOING DISCLAIMER AND LIMITATIONS OF LIABILITY ARE INTENDED TO BE ONLY AS BROAD AS IS PERMITTED UNDER THE LAWS OF THE STATE OF NEW JERSEY. IF ANY PORTION OF THESE PROVISIONS IS HELD TO BE INVALID UNDER THE LAWS OF THE STATE OF NEW JERSEY, THE INVALIDITY OF SUCH PORTION SHALL NOT AFFECT THE VALIDITY OF THE REMAINING PORTIONS OF THE APPLICABLE SECTIONS.
VIII. Compliance with Applicable Laws
You are solely responsible for ensuring compliance with the laws of your specific jurisdiction. Regenacy makes no claims concerning whether the content on this website may be downloaded, viewed, or be appropriate for use outside of the United States.
IX. Severability; Waiver
X. Disputes; Governing Law; Jurisdiction